4-Bromo-2-(difluoromethyl)pyridine: Handling & Application Guide

4-Bromo-2-(difluoromethyl)pyridine is a fluorinated heteroaromatic building block widely employed in medicinal chemistry and materials science for the introduction of both a bromine handle—enabling diverse cross-coupling chemistry—and a metabolically stable difluoromethyl group onto a pyridine scaffold.

Chemical Name

4-Bromo-2-(difluoromethyl)pyridine

Molecular Formula

C6H4BrF2N

Molecular Weight

208.01 g/mol

Key Functional Groups

Aryl bromide, difluoromethyl group, pyridine ring nitrogen

Primary Application

Synthetic intermediate in medicinal chemistry and agrochemical research

Recommended Storage

Cool, dry, well-ventilated area away from moisture and incompatible materials

Aladdin SKU

B586618

Chemical Identity and Key Properties

4-Bromo-2-(difluoromethyl)pyridine (CAS to be confirmed; see review flags) is a halogenated, fluorinated pyridine derivative bearing two distinct reactive or bioisosteric elements: an aryl bromide at the 4-position and a difluoromethyl (–CHF₂) substituent at the 2-position of the pyridine ring.

The difluoromethyl group is a well-established bioisostere for hydroxyl, thiol, and methyl groups in drug design, conferring increased lipophilicity, metabolic stability, and membrane permeability relative to the parent –CH₃ or –OH analogues. The C–F bonds resist cytochrome P450-mediated oxidative metabolism, making –CHF₂-containing compounds attractive leads in pharmaceutical discovery.

The aryl bromide functionality provides a versatile synthetic handle for palladium-catalysed cross-coupling reactions (e.g., Suzuki–Miyaura, Buchwald–Hartwig, Negishi, Sonogashira), as well as directed metalation and nucleophilic aromatic substitution strategies. Together, these two features make the compound a bifunctional building block with broad utility in synthetic programmes.

Handling, Safety, and Storage Guidelines

Personal Protective Equipment (PPE): Always wear appropriate nitrile gloves, safety spectacles or goggles, and a laboratory coat when handling 4-Bromo-2-(difluoromethyl)pyridine. Work in a chemical fume hood to minimise inhalation exposure to vapours or aerosols.

Storage: Store in a tightly sealed container in a cool (typically 2–25 °C; confirm with product CoA), dry, well-ventilated area. Protect from moisture to prevent hydrolysis of the difluoromethyl group under prolonged, extreme conditions. Keep away from strong oxidisers, strong bases, and reactive metals.

Waste Disposal: Dispose of waste material and containers in accordance with local, regional, and national environmental regulations. Do not pour down drains. Halogenated organic waste should be segregated and handled by a licensed waste contractor.

Spill Response: For small spills, absorb with inert material (e.g., vermiculite or dry sand), collect into a labelled, closeable waste container, and decontaminate the area with appropriate solvent. Refer to the Safety Data Sheet (SDS) for full emergency response guidance.

Note: Specific GHS hazard classifications, signal words, and H/P statements should be verified against the current product SDS available from Aladdin Scientific (SKU B586618).

Synthetic Applications and Reaction Protocols

Suzuki–Miyaura Cross-Coupling: The aryl bromide at the 4-position undergoes efficient palladium-catalysed coupling with arylboronic acids and boronate esters. Typical conditions employ Pd(PPh₃)₄ or Pd(dppf)Cl₂ as catalyst (1–5 mol%), an aqueous carbonate or phosphate base (e.g., K₂CO₃, 2 equiv.), and a mixed solvent system such as DMF/H₂O or THF/H₂O at 80–100 °C. This protocol readily installs aryl, heteroaryl, vinyl, and alkyl (with appropriate boronate partners) groups at C-4 of the pyridine ring.

Buchwald–Hartwig Amination: C–N bond formation at the 4-position is achievable using palladium catalysis with a bulky phosphine ligand (e.g., BINAP, SPhos, or RuPhos), an amine nucleophile, and a base such as Cs₂CO₃ in toluene or dioxane at elevated temperature. This transforms the aryl bromide into a diarylamine or dialkylamine functionality, useful for building amine-containing drug-like scaffolds.

Sonogashira Coupling: Terminal alkynes can be coupled to the aryl bromide under Pd/Cu co-catalysis (e.g., Pd(PPh₃)₂Cl₂/CuI) in the presence of a trialkylamine base (Et₃N or diisopropylamine) in DMF or acetonitrile at 50–80 °C to afford internal alkyne products.

Directed Metalation / Lithium–Halogen Exchange: Treatment with n-BuLi or t-BuLi at –78 °C in THF effects lithium–halogen exchange at C-4, generating an aryllithium intermediate that can be quenched with a range of electrophiles (aldehydes, ketones, DMF, TMSCl) to introduce diverse functional groups.

Protocol parameters above are representative literature conditions. Researchers should optimise reaction conditions, including catalyst loading, base, solvent, temperature, and time, for their specific substrates and scales. Confirm suitability by consulting peer-reviewed literature and performing small-scale feasibility experiments.

Role of the Difluoromethyl Group in Drug Discovery

The difluoromethyl group (–CHF₂) has emerged as a privileged motif in modern medicinal chemistry. Its unique combination of properties stems from the high electronegativity of fluorine, the remaining C–H bond (capable of hydrogen bond donation), and the moderate lipophilicity increment relative to unsubstituted methyl.

Hydrogen Bond Donation: Unlike the trifluoromethyl group (–CF₃), the –CHF₂ group retains one C–H bond that can act as a weak hydrogen bond donor, enabling additional interactions with enzyme active sites.

Metabolic Stability: The C–F bonds are highly resistant to oxidative metabolism by cytochrome P450 enzymes, which typically target sp³ C–H bonds. Replacement of a methyl or methylene group with –CHF₂ frequently improves in vitro and in vivo metabolic half-life.

Lipophilicity Tuning: Incorporation of –CHF₂ modestly increases logP relative to –CH₃, improving membrane permeability while maintaining aqueous solubility better than –CF₃.

Bioisosteric Replacement: –CHF₂ serves as a bioisostere for –OH and –SH, mimicking their hydrogen-bonding capability while dramatically improving metabolic and chemical stability.

These properties have led to the inclusion of –CHF₂-bearing pyridine fragments in numerous drug discovery programmes targeting kinases, proteases, and GPCRs. 4-Bromo-2-(difluoromethyl)pyridine therefore offers researchers a convenient entry point to construct such privileged scaffolds.

Quality, Specification, and Ordering Information

Aladdin Scientific supplies 4-Bromo-2-(difluoromethyl)pyridine under SKU B586618. Each batch is accompanied by a Certificate of Analysis (CoA) confirming identity (typically by ¹H NMR and/or GC-MS), purity (verify exact specification on the current CoA), and physical data.

Specification Checklist for Procurement:

• Confirm purity specification (e.g., ≥95% or ≥97% by GC or HPLC) on the CoA prior to use in critical synthetic steps.
• Request SDS for full hazard classification, GHS pictograms, first-aid measures, and disposal guidance before first use.
• Check lot-specific NMR or MS data for structural confirmation.
• For regulatory or GMP-adjacent work, enquire about additional analytical support, including elemental analysis or residual solvent data.

Ordering: Place orders directly through the Aladdin Scientific website or authorised distributors. For bulk quantities, custom packaging, or quotations, contact Aladdin Scientific technical sales. Standard lead times apply; confirm availability at time of order.

Returns and Quality Concerns: If the received material does not meet stated specifications, contact Aladdin Scientific customer service with the lot number and CoA for resolution in accordance with the company's returns and refund policy.

Frequently asked questions

What cross-coupling reactions are compatible with 4-Bromo-2-(difluoromethyl)pyridine?

The aryl bromide at C-4 is compatible with a wide range of palladium-catalysed cross-coupling reactions, including Suzuki–Miyaura (boronic acids/esters), Buchwald–Hartwig (amines), Negishi (organozinc), and Sonogashira (terminal alkynes) couplings. Lithium–halogen exchange at –78 °C also provides a versatile aryllithium intermediate for reactions with electrophiles.

Is the difluoromethyl group in this compound stable under typical cross-coupling conditions?

Yes, the –CHF2 group is generally stable under the aqueous base and moderate temperatures (80–100 °C) used in Suzuki–Miyaura and similar cross-coupling protocols. However, prolonged exposure to strongly basic or strongly acidic conditions may affect the group; researchers should verify stability under their specific reaction conditions.

How should 4-Bromo-2-(difluoromethyl)pyridine be stored to maintain integrity?

The compound should be stored in a tightly sealed container in a cool, dry, and well-ventilated area, protected from moisture and incompatible reagents such as strong oxidisers and bases. Confirm the recommended storage temperature range from the current Aladdin Scientific CoA or SDS for SKU B586618.

What is the significance of the difluoromethyl group in drug discovery applications?

The –CHF2 group serves as a bioisostere for –OH and –SH, provides a weak hydrogen bond donor through its C–H bond, improves metabolic stability by resisting cytochrome P450-mediated oxidation, and modestly increases lipophilicity to enhance membrane permeability. These properties make it a highly valued motif in lead optimisation programmes.

How can I confirm the purity and identity of the received batch?

Aladdin Scientific provides a Certificate of Analysis (CoA) with each batch of B586618, detailing purity data (typically by GC or HPLC) and structural confirmation (by 1H NMR and/or GC-MS). Researchers can also perform in-house verification using standard analytical techniques before use in sensitive synthetic steps.

References

1. Gouverneur, V.; Müller, K. (Eds.) Fluorine in Pharmaceutical and Medicinal Chemistry: From Biophysical Aspects to Clinical Applications. Imperial College Press, 2012.
2. Hagmann, W. K. The Many Roles for Fluorine in Medicinal Chemistry. J. Med. Chem. 2008, 51, 4359–4369. doi:10.1021/jm800219f
3. Miyaura, N.; Suzuki, A. Palladium-Catalyzed Cross-Coupling Reactions of Organoboron Compounds. Chem. Rev. 1995, 95, 2457–2483. doi:10.1021/cr00039a007
4. Yanagisawa, S.; Sudo, T.; Nishi, R.; Itami, K. Direct C–H Arylation of Heterocycles via Palladium Catalysis. J. Am. Chem. Soc. 2006, 128, 11748–11749.
5. Aladdin Scientific. Product Page: 4-Bromo-2-(difluoromethyl)pyridine, SKU B586618. Retrieved from the Aladdin Scientific website.

Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.